Top Back to top

Graft-versus-Host Disease after donor-derived chimeric antigen receptor T-cell infusion post allogeneic HSCT

Transplant Complications Working Party (TCWP)
Cellular Therapy & Immunobiology Working Party (CTIWP)
Study number:
 
Type of transplant:
 
Diseases:
 
Short title:
Chronic GVHD over time
Study status:
Data collection
Deadline for data collection:
 
Study design:
Retrospective
Primary objective:
To determine cumulative incidence of acute and chronic GvHD at 100 and 365 days, after donor-derived CAR T-cell infusion post allo-HSCT.
Key inclusion criteria:
Recipients of Allogeneic HSCT; Disease Relapse after Allogeneic HSCT; Donor derived CAR T-cell infusion after Allogeneic HSCT.
Country:
 
Principal investigator:
Guillermo Ortí
Principal investigator email:
gorti@vhio.net